about
Commentary on Degenhardt et al. (2014): Regional variation in the global burden of disease attributable to opioid dependence-where do the data come from and does population size matter?Cross-system data linkage for treatment outcome evaluation: lessons learned from the California Treatment Outcome ProjectUsing administrative data for longitudinal substance abuse research.Characterizing longitudinal health state transitions among heroin, cocaine, and methamphetamine users.Perceived neighborhood safety, recovery capital, and successful outcomes among mothers 10 years after substance abuse treatmentConsistency in Self-Reports of Drug Use Frequency by High-Risk Offenders Over a 5-Year IntervalComparative Effectiveness of California's Proposition 36 and Drug Court Programs Before and After Propensity Score MatchingA Marginal Structural Modeling Approach to Assess the Cumulative Effect of Drug Treatment on the Later Drug Use AbstinenceLong-term outcomes among drug-dependent mothers treated in women-only versus mixed-gender programs.Maternal mental health and children's internalizing and externalizing behaviors: Beyond maternal substance use disorders.Benefit-cost in the California treatment outcome project: does substance abuse treatment "pay for itself"?Effects of a randomized contingency management intervention on opiate abstinence and retention in methadone maintenance treatment in China.Mortality among substance-using mothers in California: a 10-year prospective studyMortality among individuals accessing pharmacological treatment for opioid dependence in California, 2006-10.Hepatitis C among methadone maintenance treatment patients in Shanghai and Kunming, ChinaHispanic parenting women in women-only versus mixed-gender drug treatment: a 10-year prospective study.Defining dosing pattern characteristics of successful tapers following methadone maintenance treatment: results from a population-based retrospective cohort studyA mixed methods approach to identifying factors related to voluntary HIV testing among injection drug users in Shanghai, China.Gender differences in mortality among treated opioid dependent patients.Heterogeneity of Mental Health Service Utilization and High Mental Health Service Use Among Women Eight Years After Initiating Substance Use Disorder Treatment.Ethnic differences in utilization of drug treatment services and outcomes among Proposition 36 offenders in California.Long-term outcomes after randomization to buprenorphine/naloxone versus methadone in a multi-site trialClient and program factors associated with dropout from court mandated drug treatment.Children of treated substance-abusing mothers: a 10-year prospective study.Long-term course of opioid addiction.Implementation of a statewide outcome monitoring system: lessons learned from substance abuse treatment provider staff.Gender and race/ethnic differences in the persistence of alcohol, drug, and poly-substance use disorders.Gender differences in the effects of childhood adversity on alcohol, drug, and polysubstance-related disorders.The costs of crime during and after publicly funded treatment for opioid use disorders: a population-level study for the state of California.Evaluation of the Substance Abuse and Crime Prevention Act: client characteristics, treatment completion and re-offending three years after implementation.Evaluation of the substance abuse and crime prevention act: treatment clients and program types during the first year of implementation.Cost-Effectiveness of Publicly Funded Treatment of Opioid Use Disorder in California.Treatment outcomes among women and men methamphetamine abusers in California.Differences by Veteran/civilian status and gender in associations between childhood adversity and alcohol and drug use disorders.Utilization and outcomes of mental health services among patients in drug treatment.Polydrug use and its association with drug treatment outcomes among primary heroin, methamphetamine, and cocaine users.Outcomes of drug and alcohol treatment programs among American Indians in California.Psychosocial Factors that Shape Substance Abuse and Related Mental Health of Women Military Veterans who Use Community-Based Services.Offender diversion into substance use disorder treatment: the economic impact of California's proposition 36Gender Differences in Use of Complementary and Integrative Health by U.S. Military Veterans with Chronic Musculoskeletal Pain
P50
Q30837333-FDF07DB3-6F66-451C-BC69-12E548751C08Q31151002-847E1CD9-8228-455F-A947-D3471FC65A2BQ31168666-8DD4CC6A-12F2-41AF-96D7-E795CE7E92DFQ33810775-8A161CAD-4E4D-493C-981B-821705705F20Q33976597-89AF68BB-A256-43AF-AAE4-203B043B232DQ34093160-89EC04BC-B377-4388-AF76-BE51C03A3CADQ34372607-4591E451-08B9-4296-8ABB-D9002F5A49E5Q34960408-B762FB36-06E1-43FF-B67B-1DC87AF8B851Q35091308-8358BCDA-5C60-486D-B6E2-B70BB4766DCDQ35146755-2C6E9B59-DEF8-45B3-B4EC-72F8BDA26ED4Q35193555-4B34EAD2-A261-4E39-8A8D-C71B73279FE7Q35216327-186F26D0-FC42-4F5A-9FEA-7F4968F859A5Q35581146-748D8ACF-D567-4918-BF54-7D1770EF0FB9Q35674032-A8B7D1AA-DF0C-4652-8655-F097DBA9D796Q35773225-EFC5E1C8-0734-4FA0-959A-AC6736842AC8Q35907153-0CF8A499-34A6-4923-84DE-16A817F6B9F5Q36037158-D13D393F-D9CB-46B2-AAF0-962B94B060D1Q36044273-BE4B329D-92D8-4173-B3DA-5BD5DBCC86EEQ36090298-1A506460-4F8A-42A5-BC03-5D61BE8C4955Q36322481-E0C2BB05-2FF5-40D7-8369-2988D1B91C8CQ36415634-DB47F040-B013-4A61-91BD-DC63FD5ED4F0Q36711893-4107CFE6-1D4F-4BB7-9647-E3B71FCFBFECQ37245110-0B3E6D03-ED5E-4754-AAF6-76BC8FE58F9DQ37427947-1F26A7F7-7ECB-47FC-88E9-A8937A39E4E2Q38369658-EE97C8F1-7595-4FE4-BE4E-0B31E87F76EFQ38454392-255FF67F-1A72-4D4C-8CF7-816F6C32AB88Q38889399-9BBC1EEC-07FE-4D33-9F41-253B102D9836Q38930417-9BE586D9-66BB-4ECE-9739-F25831403487Q39095973-38C49A55-9B4A-4375-8801-E2DCC6994810Q40234231-207D772B-0D9A-4F77-A9EC-AE3441347384Q40493025-C141BD87-53AB-4B9F-BF58-583FC735340AQ44351263-3F3BE3FE-B265-4457-A4E8-3FB1A5702BDDQ45276973-FC1F1FD2-0B81-4889-93C0-27F2D209A852Q45325686-ABA2F4F1-0F90-4FC5-9C39-6B8BCC2DD628Q46202226-0FBD455E-18C6-4D8F-A372-8E9781389181Q46433374-2C0760A7-0055-45EE-9B51-38856F40D0E1Q51919734-4D0F6F88-35BA-415D-9BCE-764B9A7C72B1Q52683495-29BCD2F4-FEE9-4A6B-880A-7F300D934A71Q86617084-57E77E95-82D1-4CBF-A606-AEADFEC7430CQ91264567-FBC967B5-3117-4B1B-811C-8F47793856C2
P50
description
researcher ORCID ID = 0000-0002-3478-9957
@en
wetenschapper
@nl
name
Elizabeth Evans
@ast
Elizabeth Evans
@en
Elizabeth Evans
@es
Elizabeth Evans
@nl
type
label
Elizabeth Evans
@ast
Elizabeth Evans
@en
Elizabeth Evans
@es
Elizabeth Evans
@nl
prefLabel
Elizabeth Evans
@ast
Elizabeth Evans
@en
Elizabeth Evans
@es
Elizabeth Evans
@nl
P21
P31
P496
0000-0002-3478-9957